These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


504 related items for PubMed ID: 20587671

  • 1. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE, Perrin K.
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [Abstract] [Full Text] [Related]

  • 2. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD.
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD.
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD.
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD.
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [Abstract] [Full Text] [Related]

  • 6. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
    Mast TC, Khawaja S, Espinoza F, Paniagua M, Del Carmen LP, Cardellino A, Sánchez E.
    Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
    [Abstract] [Full Text] [Related]

  • 7. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD.
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [Abstract] [Full Text] [Related]

  • 8. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.
    Field EJ, Vally H, Grimwood K, Lambert SB.
    Pediatrics; 2010 Sep; 126(3):e506-12. PubMed ID: 20732946
    [Abstract] [Full Text] [Related]

  • 9. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.
    Patel MM, Tate JE, Selvarangan R, Daskalaki I, Jackson MA, Curns AT, Coffin S, Watson B, Hodinka R, Glass RI, Parashar UD.
    Pediatr Infect Dis J; 2007 Oct; 26(10):914-9. PubMed ID: 17901797
    [Abstract] [Full Text] [Related]

  • 10. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C.
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [Abstract] [Full Text] [Related]

  • 11. Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States.
    Flores AR, Szilagyi PG, Auinger P, Fisher SG.
    Pediatrics; 2010 Feb; 125(2):e191-8. PubMed ID: 20100749
    [Abstract] [Full Text] [Related]

  • 12. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002.
    Charles MD, Holman RC, Curns AT, Parashar UD, Glass RI, Bresee JS.
    Pediatr Infect Dis J; 2006 Jun; 25(6):489-93. PubMed ID: 16732145
    [Abstract] [Full Text] [Related]

  • 13. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H.
    Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
    [Abstract] [Full Text] [Related]

  • 14. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M, Schödel F.
    Vaccine; 2009 Dec 30; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR, Laserson KF, Ojwando J, Nyambane G, Ssempijja V, Audi A, Nyakundi D, Oyieko J, Dallas MJ, Ciarlet M, Neuzil KM, Breiman RF.
    Vaccine; 2012 Apr 27; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [Abstract] [Full Text] [Related]

  • 16. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2007 Jan 27; 119(1):171-82. PubMed ID: 17200286
    [Abstract] [Full Text] [Related]

  • 17. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A, Santosham M.
    Expert Rev Vaccines; 2008 Dec 27; 7(10):1475-80. PubMed ID: 19053204
    [Abstract] [Full Text] [Related]

  • 18. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states.
    Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD.
    J Infect Dis; 2010 Jun 01; 201(11):1617-24. PubMed ID: 20402596
    [Abstract] [Full Text] [Related]

  • 19. Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine.
    Vesikari T, Karvonen A, Ferrante SA, Kuter BJ, Ciarlet M.
    Pediatr Infect Dis J; 2010 Oct 01; 29(10):957-63. PubMed ID: 20442684
    [Abstract] [Full Text] [Related]

  • 20. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.
    Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD.
    Pediatr Infect Dis J; 2010 Jun 01; 29(6):489-94. PubMed ID: 20354464
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.